Jeremy I Hawker1, Sue Smith2, Gillian E Smith2, Roger Morbey2, Alan P Johnson3, Douglas M Fleming4, Laura Shallcross5, Andrew C Hayward5. 1. Field Epidemiology Service, Public Health England, 5 St Philip's Place, Birmingham B3 2PW, UK jeremy.hawker@phe.gov.uk. 2. Real-time Syndromic Surveillance Team, Public Health England, 5 St Philip's Place, Birmingham B3 2PW, UK. 3. Department of Healthcare Associated Infection and Antimicrobial Resistance, Centre for Infectious Disease Surveillance and Control, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK. 4. Royal College of General Practitioners Research and Surveillance Centre, Birmingham B17 9DB, UK. 5. Department of Infection and Population Health, University College London, London NW3 4PQ, UK.
Authors: Ansal Shah; Julie Ann Justo; P Brandon Bookstaver; Joseph Kohn; Helmut Albrecht; Majdi N Al-Hasan Journal: Antimicrob Agents Chemother Date: 2017-04-24 Impact factor: 5.191
Authors: Koen B Pouwels; F Christiaan K Dolk; David R M Smith; Julie V Robotham; Timo Smieszek Journal: J Antimicrob Chemother Date: 2018-02-01 Impact factor: 5.790
Authors: F Christiaan K Dolk; Koen B Pouwels; David R M Smith; Julie V Robotham; Timo Smieszek Journal: J Antimicrob Chemother Date: 2018-02-01 Impact factor: 5.790
Authors: Timo Smieszek; Koen B Pouwels; F Christiaan K Dolk; David R M Smith; Susan Hopkins; Mike Sharland; Alastair D Hay; Michael V Moore; Julie V Robotham Journal: J Antimicrob Chemother Date: 2018-02-01 Impact factor: 5.790